GCG and type 2 diabetes mellitus: These data contrast our previous results with saxagliptin [2], other favorable observations with linagliptin [29], and the pathophysiologic rationale that multiple advantageous effects on vascular function structure by GLP-1 based therapies have been demonstrated for patients with type 2 diabetes [30].